Christopher Mason
Direttore/Membro del Consiglio presso KRYSTAL BIOTECH, INC.
Patrimonio netto: - $ in data 30/06/2024
Provenienza dei contatti di primo grado di Christopher Mason
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
University College London
362
| College/University | Other Consumer Services | 362 |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field.
37
| Non-Profit Organization | Medical/Nursing Services | 37 |
| Public Company | Biotechnology | 33 | |
| Extinct | Biotechnology | 29 | |
Oribiotech Ltd.
 Oribiotech Ltd. BiotechnologyHealth Technology Oribiotech Ltd. Engages in Cell and Gene Therapy (CGT) manufacturing. The company was founded by Farlan Veraitch and Chris Mason on September 2, 2015 and is headquartered in London, the United Kingdom.
6
| Holding Company | Biotechnology | 6 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Christopher Mason tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Corporate Officer/Principal General Counsel Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| ROCHE HOLDING AG | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| MORGAN STANLEY | Investment Managers | Corporate Officer/Principal | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| BP PLC | Integrated Oil | Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Alta Partners Management Co. LP
 Alta Partners Management Co. LP Investment ManagersFinance Alta Partners Management Co. LP (Alta Partners) is a venture capital firm founded in 1996 by Jean Deleage, Guy Paul Nohra, Marino Polestra and Garrett P. Gruener. The firm is headquartered in Jackson, Wyoming. | Investment Managers | Private Equity Investor | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
New River Pharmaceuticals, Inc.
 New River Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New River Pharmaceuticals, Inc. develops pharmaceutical products. Its product candidates in clinical development are an amphetamine derivative (NDA filed) and an opioid derivative that they believe will provide alternatives to marketed drugs. The company was founded by Randal J. Kirk in 1996 and is headquartered in Radford, VA. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO | |
The Medical Research Council
 The Medical Research Council Miscellaneous Commercial ServicesCommercial Services The Medical Research Council provides human healthcare and social services. It offers funding for biomedical spectrum, fundamental lab-based science, clinical trials and all major disease areas. The company was founded in 1913 and is headquartered in Swindon, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
| PRECIGEN, INC. | Biotechnology | General Counsel Chief Operating Officer | |
| SHIRE | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Arcturus Therapeutics, Inc.
 Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics, Inc. engages in the development of technology and therapeutics for rare diseases. It specializes in the application of application of ribonucleic acid technologies for the treatment of disease. The company was founded by Joseph E. Payne and Padmanabh Chivukula in 2013 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of Virginia | College/University | Graduate Degree | |
| Stanford University | College/University | Undergraduate Degree Doctorate Degree Masters Business Admin | |
| KUANGCHI SCIENCE LIMITED | Aerospace & Defense | Director/Board Member | |
| University of Oxford | College/University | Graduate Degree Undergraduate Degree | |
| Imperial College London | College/University | Undergraduate Degree Corporate Officer/Principal Corporate Officer/Principal | |
| The University of Manchester | College/University | Doctorate Degree Director/Board Member | |
| University of Cambridge | College/University | Doctorate Degree Corporate Officer/Principal Graduate Degree | |
| ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| McGill University | College/University | Undergraduate Degree Undergraduate Degree | |
| Miami University | College/University | Undergraduate Degree Graduate Degree | |
| Yale University | College/University | Undergraduate Degree Doctorate Degree | |
| New York University | College/University | Graduate Degree Doctorate Degree | |
| University of Toronto | College/University | Graduate Degree Doctorate Degree | |
| University of California, Berkeley | College/University | Masters Business Admin Doctorate Degree | |
| Villanova University | College/University | Graduate Degree Graduate Degree | |
The Institute of Electrical & Electronics Engineers, Inc.
 The Institute of Electrical & Electronics Engineers, Inc. Miscellaneous Commercial ServicesCommercial Services The Institute of Electrical & Electronics Engineers, Inc. is a non-profit organization that owns and operates technical professional association. It provides membership and services, societies and communities support, publication services, and conferences and events. The company was founded in 1884 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
PricewaterhouseCoopers LLP (United Kingdom)
 PricewaterhouseCoopers LLP (United Kingdom) Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLP engages in the provision of accounting services. Its services include audit and assurance, accounting advisory, risk assurance, tax management, corporate insolvency, life cycle assessment, forensic services, private equity advisory, and financial reporting valuations. The company is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
| The Hong Kong University of Science & Technology | College/University | Undergraduate Degree | |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal | |
| King's College London | College/University | Corporate Officer/Principal Graduate Degree | |
| 8990 HOLDINGS, INC. | Homebuilding | Director/Board Member | |
| Harvard Medical School | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ALLAKOS INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Arcturus Therapeutics Ltd.
 Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics Ltd. engages in the provision of RNA medicines, which focuses on liver and respiratory diseases. Its RNA medicines include mRNA; siRNA, miRNA, and ASO;, CRISPR, TALEN, and meganucleases; and Replicon RNA and DNA. The company was founded by Joseph Payne in March 2013 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| The Institute for Fiscal Studies (Research Firm) | Investment Managers | Analyst-Equity Economist | |
Achilles Therapeutics UK Ltd.
 Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | Biotechnology | Founder Founder | |
| ACHILLES THERAPEUTICS PLC | Pharmaceuticals: Major | Founder Founder | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| INTELLIA THERAPEUTICS, INC. | Biotechnology | Public Communications Contact Chief Tech/Sci/R&D Officer | |
Sonoma Biotherapeutics, Inc.
 Sonoma Biotherapeutics, Inc. BiotechnologyHealth Technology Sonoma Biotherapeutics, Inc. provides research, development, and manufacturing capabilities in cell therapy and genetic engineering. The company was founded by Jeffrey A. Bluestone, Fred Ramsdell, Alexander Rudensky, and Qizhi Tang in 2019 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 31 |
| Regno Unito | 12 |
| Hong Kong | 3 |
| Canada | 3 |
| Svizzera | 2 |
Settori
| Health Technology | 23 |
| Consumer Services | 18 |
| Finance | 4 |
| Commercial Services | 4 |
| Energy Minerals | 2 |
Posizioni
| Director/Board Member | 325 |
| Corporate Officer/Principal | 217 |
| Independent Dir/Board Member | 81 |
| Undergraduate Degree | 56 |
| Chief Executive Officer | 45 |
Contatti più connessi
| Insiders | |
|---|---|
| Daniel Janney | 47 |
| Robin Smith | 46 |
| David Knox | 27 |
| Scott Requadt | 23 |
| Katina Dorton | 22 |
| Krish S. Krishnan | 19 |
| Junaid Bajwa | 18 |
| DeAnne Shirley Julius | 17 |
| Karah Parschauer | 16 |
| Timothy Lu | 16 |
| Jacques Suzanne | 15 |
| Arthur Tzianabos | 15 |
| Ann Lee | 15 |
| Julia Prescot | 15 |
| Sarah Whitney | 15 |
- Borsa valori
- Insiders
- Christopher Mason
- Connessioni Società
